Search

Home > New FDA Approvals > 129 - Fostamatinib for CITP; KL1333 for mitochondrial diseases; Praxbind reversal agent for Pradaxa; therapy for inherited rickets; FDA statements on arsenic in rice and medical device safety and innovation
Podcast: New FDA Approvals
Episode:

129 - Fostamatinib for CITP; KL1333 for mitochondrial diseases; Praxbind reversal agent for Pradaxa; therapy for inherited rickets; FDA statements on arsenic in rice and medical device safety and innovation
Category: Science & Medicine
Duration: 00:10:43
Publish Date: 2018-04-19 06:00:00
Description:

April 19, 2018

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com

0:58 Rigel Announces FDA Approval of TAVALISSE™ (fostamatinib disodium hexahydrate) for Chronic Immune Thrombocytopenia (ITP) in Adult Patients https://www.prnewswire.com/news-releases/rigel-announces-fda-approval-of-tavalisse-fostamatinib-disodium-hexahydrate-for-chronic-immune-thrombocytopenia-itp-in-adult-patients-300631702.html

3:27 NeuroVive's KL1333 Receives FDA Orphan Drug Designation for Treatment of Mitochondrial Diseases https://www.prnewswire.com/news-releases/neurovives-kl1333-receives-fda-orphan-drug-designation-for-treatment-of-mitochondrial-diseases-300632009.html

4:57 FDA Provides Full Approval to Praxbind, Specific Reversal Agent for Pradaxa https://www.prnewswire.com/news-releases/fda-provides-full-approval-to-praxbind-specific-reversal-agent-for-pradaxa-300631175.html

7:00 FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia https://www.prnewswire.com/news-releases/fda-approves-first-therapy-for-rare-inherited-form-of-rickets-x-linked-hypophosphatemia-300631478.html

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm604810.htm 

9:24 Statement by Dr. Susan Mayne on FDA efforts to reduce consumer exposure to arsenic in rice https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm604807.htm

9:35 Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to enhance and modernize the FDA’s approach to medical device safety and innovation https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm604672.htm

Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com.

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0